Investor Presentation • Sep 14, 2023
Investor Presentation
Open in ViewerOpens in native device viewer

14 SEPTEMBER 2023



Martin Rasmussen CEO
Introduction Quarterly highlights and subsequent events First harvest Successful financing Next build-out phase Summary and outlook

Bjarne Martinsen
CFO
OPTIMAL WATER TEMPERATURES
OXYGEN-RICH AND CLEAN ARCTIC SEAWATER
LOW ENERGY COSTS. NO LIFTING, HEATING OR COOLING

1
2
3
NO PROBLEMS WITH SALMON LICE AND POISONOUS ALGAE 1

COLLECTION AND RECYCLING BIO WASTE = COMMERCIAL VALUE 3









Q2 2023
Bank and equity financing secured to fund next build-out phase (8,000 t) at Kvalnes and shared infrastructure to enable production volume up to 40,000 t

Build-out plan revealed: Roadmap to 40,000 t at Kvalnes

Successful first production cycle completed with strong biological results and exceptional survival rate
June/July harvest chosen to mitigate project execution risks for Kvalnes expansion


Kvalnes expansion in full momentum
Salmon sold to strategically selected European distributors
Very positive customer feedback, with filet colour and yield highlighted






Source: Andfjord Salmon, The Norwegian Veterinary Institute's Fish Health Report 2022, Nofima



Average weight per fish (grams)
40% ahead of expectations based on



An industry leading survival rate
Superior share of first harvest of salmon
Average weight per fish Total biomass
Head-On Gutted (HOG)




"Very satisfied with yield and colour. Willing to pay more for the next batch." Polish customer that produces fresh, smoked and frozen salmon products
"Very satisfied and would have liked to buy more if it was available". Dutch customer

"Very pleased, and positively surprised by the excellent colour". Irish customer
"So satisfied that they returned to purchase a lot more fish". Lithuanian customer that delivers fresh and smoked fish products




| Statement of comprehensive income | Q2 2023 | Q2 2022 | HY 2023 | HY 2022 | 2022 |
|---|---|---|---|---|---|
| 1.4 – 30.6 Unaudited |
1.4 – 30.6 Unaudited |
1.1 – 30.6 Unaudited |
1.1 – 30.6 Unaudited |
1.1 – 31.12 |
|
| Operating income and expenses |
|||||
| Revenue from contracts with customers |
9 625 | - | 9 625 | - | - |
| Other income |
- | - | - | 32 | 113 |
| Total operating income |
9 625 | - | 9 625 | 32 | 113 |
| Change in biological assets at cost and other inventories |
-1 829 | - | -1 864 | - | 700 |
| Cost of materials | -17 512 | - | -22 047 | - | -12 704 |
| Fair value adjustments of biological assets | 13 294 | - | 25 707 | - | 14 285 |
| Employee benefit expenses | -5 676 | -2 954 | -12 389 | -8 018 | -23 211 |
| Depreciation and amortisation expenses |
-6 165 | -763 | -12 317 | -1 600 | -13 603 |
| Other operating expenses |
-9 830 | -6 699 | -18 748 | -10 753 | -21 691 |
| Total operating expenses |
-27 717 | -10 416 | -41 657 | -20 371 | -56 224 |
| Operating profit/loss | -18 092 | -10 416 | -32 032 | -20 340 | -56 111 |
| Financial income and expenses |
|||||
| Financial income |
- | - | - | - | 1 836 |
| Net financial costs | -143 | -302 | -283 | -304 | -2 402 |
| Net financial result |
-143 | -302 | -283 | -304 | -566 |
| Profit/loss for the period |
-18 235 | -10 718 | -32 315 | -20 644 | -56 677 |


| Assets | 30.06.2023 - Unaudited |
31.12.2022 | 30.06.2022 - Unaudited |
|---|---|---|---|
| Intangible assets |
12 570 | 8 556 | 3 599 |
| Property, plant & equipment |
521 109 | 498 386 | 481 911 |
| Right-of-use assets |
19 496 | 22 539 | 24 104 |
| Other non-current assets |
71 | 89 | 106 |
| Total non-current assets |
553 246 | 529 570 | 509 720 |
| Biological assets |
29 836 | 14 285 | 6 673 |
| Other inventories |
- | 1 162 | - |
| Trade and other receivables |
10 987 | - | - |
| Other current assets |
152 157 | 7 803 | 8 922 |
| Cash and cash equivalents |
94 698 | 82 911 | 191 191 |
| Total current assets |
287 678 | 106 161 | 206 787 |
| Total assets |
840 924 | 635 731 | 716 507 |
All amounts in 1000 NOK


| Equity and liabilities | 30.06.2023 - Unaudited |
31.12.2022 | 30.06.2022 - Unaudited |
|---|---|---|---|
| Total equity | 643 061 | 475 704 | 515 300 |
| Borrowings | 63 417 | 67 375 | 122 562 |
| Lease liabilities | 11 027 | 13 296 | 14 517 |
| Total non-current liabilities |
74 444 | 80 671 | 137 079 |
| Borrowings | 59 417 | 56 168 | 3 166 |
| Lease liabilities | 4 514 | 4 683 | 3 520 |
| Trade payables | 45 461 | 10 361 | 56 023 |
| Other current liabilities |
14 027 | 8 144 | 1 419 |
| Total current liabilities |
123 419 | 79 356 | 64 128 |
| Total liabilities | 197 863 | 160 027 | 201 207 |
| Total equity and liabilities |
840 924 | 635 731 | 716 507 |
All amounts in 1000 NOK

| Statement of cash flows |
Q2 2023 | Q2 2022 | HY 2023 | HY 2022 | 2022 |
|---|---|---|---|---|---|
| 1.4 – 30.6 Unaudited |
1.4 – 30.6 Unaudited |
1.1 – 30.6 Unaudited |
1.1 – 30.6 Unaudited |
1.1 – 31.12 |
|
| Net cash flow from operating activities |
-27 315 | -2 520 | -41 612 | -18 383 | -88 443 |
| Net cash flow from investing activities |
-20 142 | -45 300 | -33 455 | -63 586 | -90 702 |
| Net cash flow from financing activities |
88 632 | 220 140 | 86 853 | 258 243 | 247 139 |
| Net change in cash and cash equivalents |
41 176 | 172 319 | 11 787 | 176 273 | 67 993 |

Strong support from main shareholders, including:
| TOP 10 SHAREHOLDERS (PER 4 SEPTEMBER 2023) | ||
|---|---|---|
| Jerónimo Martins Agro-Alimentar, S.A. | 25.12% | Ranked the 18th largest food retailer in Europe |
| Andfjord Holding AS | 11.45% | 5,358 stores, 131,094 employees, and sales of EUR 25.4 billion (2022) |
| KG Investment Comp AS | 5.68% | Founded in 1792, listed on Euronext Lisbon with a |
| Eidsfjord Sjøfarm AS | 4.54% | market cap of EUR 14.4 billion2 |
| Skagerak Vekst AS | 3.96% | |
| OG Invest AS | 3.89% | |
| UFI AS | 3.56% | Eidsfjord Sjøfarm (part of |
| Karstein Gjersvik | 2.44% | Holmøy Maritime) produces around 25,000 |
| Verdipapirfondet DNB SMB | 2.26% | tons of salmon annually (2023e) based on conventional licenses in |
| Traaseth Property AS | 2.22% | Nordland and Troms |

Note: Stated capex numbers relate to investments (working capital/biomass, finance and operational costs not included). Estimates only.
| Stage, Kvalnes | Capex (NOK, est.) |
Added production (HOG, est.) |
Accum. production (HOG, est.) |
|---|---|---|---|
| Pilot | ~ 450m | +1,000t | 1,000t |
| 1 | Up to 1,650m | +7,000t | 8,000t |
| 2 | ~ 1,100m | +11,000t | 19,000t |
| 3 (license expansion) |
~ 0m | +4,000t | 23,000t |
| 4 | ~ 280m | +5,000t | 28,000t |
| 5 | ~ 1,100m | +12,000 t | 40,000t |

In this upcoming step of construction, the Company is planning to establish major infrastructure such as waterways and port area to support 40,000 tons of production at Kvalnes. Together with highly reputable construction partners AF Hæhre-Contur and Cflow, a budget of NOK 1,300 million plus a buffer of NOK 350 million has been estimated for the next two years.

Note: Stated capex numbers relate to investments (working capital/biomass, finance and operational costs not included). Estimates only.

In this upcoming step of construction, the Company is planning to establish major infrastructure such as waterways and port area to support 40,000 tons of production at Kvalnes. Together with highly reputable construction partners AF Hæhre-Contur and Cflow, a budget of NOK 1,300 million plus a buffer of NOK 350 million has been estimated for the next two years.


| Tons HOG Stage, Kvalnes |
Added production (HOG, est.) |
Accum. production (HOG, est.) |
|
|---|---|---|---|
| Pilot | +1,000t | 1,000t | |
| 1 | +7,000t | 8,000t | |
| 2 | +11,000t | 19,000t | |
| 3 (license expansion) |
+4,000t | 23,000t | |
| 4 | +5,000t | 28,000t | |
| 5 | +12,000 t | 40,000t |








In operation: 1,000 tons
Pilot
1 2 3
Construction start in 2026: +5,000 tons
4

+18,000 tons

Q2 2023
• Extensive preparation work carried out at Kvalnes
• Concrete injected to stabilize the sections surrounding the 12 pools
• Excavated masses from pool pits and waterways utilised for port and quay development.



| INSTALLATION OF TECHNICAL INFRASTRUCTURE |
||
|---|---|---|
| SMOLT RELEASE |








Bank and equity financing secured to fund next build-out phase (8,000 t) at Kvalnes and shared infrastructure to enable production volume up to 40,000 t
Build-out plan revealed: Roadmap to 40,000 t at Kvalnes
Successful first production cycle completed with strong biological results and exceptional survival rate
Kvalnes expansion in full momentum
Excavation of pool pits + development of harbour area main focus next 10 months
Waterway excavation commenced early September as planned
Salmon sold to various European distributors
Very positive customer feedback, with filet colour and yield highlighted


This presentation (the "Presentation") has been produced by Andfjord Salmon AS (the "Company") solely for information purposes. By reading the Presentation slides or by otherwise receiving this Presentation or the information contained herein, you agree to be bound by the following terms, conditions, and limitations:
This Presentation does not constitute an offer to sell or a solicitation of an offer to buy, or a recommendation regarding, any securities of the Company. Any failure to comply with the restrictions set out herein may constitute a violation of applicable securities laws or other regulations. No representation, warranty or undertaking, express or implied, is made by the Company, its affiliates or representatives as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein, for any purpose whatsoever. Neither the Company nor any of its affiliates or representatives shall have any responsibility or liability for any loss arising from any use of this Presentation or its contents or otherwise arising in connection with this Presentation.
This Presentation speaks as of the date hereof. All information in this Presentation is subject to updating, revision, verification, correction, completion, amendment and may change materially and without notice. None of the Company, its affiliates or representatives undertake any obligation to provide the recipient with access to any additional information or to update this Presentation or any information or to correct any inaccuracies in any such information. The information contained in this Presentation should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to reflect developments that may occur after the date of this Presentation. These materials do not purport to contain a complete description of the Company or the market(s) in which the Company operates. The contents of this Presentation are not to be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should make its own independent assessment of the information in the Presentation and should take its own professional advice in relation thereto.
This Presentation contains forward-looking information and statements relating to the business, financial performance, and results of the Company and/or industry and markets in which it operates. Forwardlooking statements are statements that are not historical facts and may be identified by words such as "aims", "anticipates", "believes", "estimates", "expects", "foresees", "intends", "plans", "predicts", "projects", "targets", and similar expressions. Such forward-looking statements are based on current expectations, estimates and projections, reflect current views with respect to future events, and are subject to risks, uncertainties, and assumptions. Forward-looking statements are not guarantees of future performance and risks, uncertainties and other important factors could cause the actual results of operations, financial condition and liquidity of the Company or the industry to differ materially from the results expressed or implied in this Presentation by such forward-looking statements. No representation is made that any of these forward-looking statements or forecasts will come to pass or that any forecast result will be achieved, and you are cautioned not to place any undue influence on any forward-looking statement.
This Presentation, and the information contained herein, does not constitute or form part of, and is not prepared or made in connection with, an offer or invitation to sell, or any solicitation of any offer to subscribe for or purchase any securities of the Company and nothing contained herein shall form the basis of any contract or commitment whatsoever. This Presentation is not a prospectus and has not been reviewed or approved by any regulatory authority, stock exchange or market place. The distribution of this Presentation or other documentation into jurisdictions other than Norway may be restricted by law. Persons into whose possession this Presentation comes should inform themselves about and observe any such restrictions.
This Presentation is subject to and governed by Norwegian law, and any dispute arising in respect of this Presentation is subject to the exclusive jurisdiction of Norwegian courts with Oslo District Court as exclusive legal venue.

ANDFJORD SALMON AS KVALNES, ANDØYA, NORWAY
ANDFJORDSALMON.COM ANDFJORD.NO
FOLLOW OUR SALMON:

69°N ANDØYA VESTERÅLEN NORWAY
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.